BROADCASTS.com

b'In this episode, we chat with David Light, Founder & CEO, of the pharmacy and analytical lab company about drug safety and quality. High-level overview of Valisure:\\n-- Valisure is the first ever pharmacy attached to a laboratory where every batch of medication is analyzed before being dispensed.\\n-- Valisure\\u2019s mission is to help ensure the safety, quality, and transparency in the medications it delivers to consumers. \\n-- All medications at Valisure come with a certificate of analysis, similar to nutritional information on food, and are sold at no additional cost.\\n-- Valisure currently rejects over 10% of the batches we analyze for problems related to dosage, dissolution (how a pill dissolves), and the presence of carcinogens.\\n-- Approximately 80% of medications in the U.S. are made from materials coming from India and China\\n-- The $2 trillion global pharma supply chain is incredibly complex and medications can touch 10-20 hands before reaching the consumer.\\n\\nGuest - David Light\\n Founder & CEO, Valisure\\n www.valisure.com\\n \\nSelected media highlights:\\nNew York Times: Zantac Products Should Not Be Sold or Used, F.D.A. Warns, Citing Cancer Danger\\nBloomberg News: Carcinogen Found by Pharmacy in Popular U.S. Diabetes Drug\\nWashington Post Feature Story: A tiny pharmacy is identifying big problems with common drugs, including Zantac\\nBloomberg Businessweek 9/16/19 Cover Story: Carcinogens Have Infiltrated the Generic Drug Supply in the U.S.\\nReuters: Online pharmacy flags possible new impurity in blood pressure drug \\n \\nValisure and Govzilla Drug Quality Scores Collaboration: Press Release (Jan 8, 2020)\\n \\nRep. DeLauro Calls for Ranitidine Ban and Reintroduces Bill: Congressional Press Release (Valisure presented at joint press conference in US Capitol Building, Jan 10, 2020)\\nSen. Warren, Cotton, Kaine and Romney Letter on Drug Safety and Reliance on China: Congressional Press Release (Valisure data directly discussed and cited in letter, Dec 9, 2019)\\n \\nCovid-related:\\nReuters (3/19/20): Potential coronavirus treatment touted by Trump already in shortage, pharmacists say\\nWSJ (2/28/20): FDA Cites Shortage of One Drug, Exposing Supply-Line Worry\\nBioSpace (3/26/20): Some Drugs Being Rationed as Suppliers Continue to See Increased Orders\\nThe Hill (3/27/20): Trump must cut our dependence on Chinese drugs \\u2014 whatever it takes\\n \\nHost - Hillary Blackburn, PharmD, MBA\\nwww.pharmacyadvisory.com\\nhttps://www.linkedin.com/in/hillary-blackburn-67a92421/ \\n@talktoyourpharmacist for Instagram and Facebook\\n@HillBlackburn Twitter'